Your browser doesn't support javascript.
loading
Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.
Iacobucci, Ilaria; Li, Yongjin; Roberts, Kathryn G; Dobson, Stephanie M; Kim, Jaeseung C; Payne-Turner, Debbie; Harvey, Richard C; Valentine, Marcus; McCastlain, Kelly; Easton, John; Yergeau, Donald; Janke, Laura J; Shao, Ying; Chen, I-Ming L; Rusch, Michael; Zandi, Sasan; Kornblau, Steven M; Konopleva, Marina; Jabbour, Elias; Paietta, Elisabeth M; Rowe, Jacob M; Pui, Ching-Hon; Gastier-Foster, Julie; Gu, Zhaohui; Reshmi, Shalini; Loh, Mignon L; Racevskis, Janis; Tallman, Martin S; Wiernik, Peter H; Litzow, Mark R; Willman, Cheryl L; McPherson, John D; Downing, James R; Zhang, Jinghui; Dick, John E; Hunger, Stephen P; Mullighan, Charles G.
Afiliação
  • Iacobucci I; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Li Y; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Roberts KG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Dobson SM; Princess Margaret Cancer Centre, University Health Network and Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 1L7, Canada.
  • Kim JC; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 2M9, Canada; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada.
  • Payne-Turner D; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Harvey RC; University of New Mexico Cancer Research and Treatment Center, Albuquerque, NM 87106, USA.
  • Valentine M; Cytogenetics Shared Resource, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • McCastlain K; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Easton J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Yergeau D; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Janke LJ; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Shao Y; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Chen IM; University of New Mexico Cancer Research and Treatment Center, Albuquerque, NM 87106, USA.
  • Rusch M; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Zandi S; Princess Margaret Cancer Centre, University Health Network and Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 1L7, Canada.
  • Kornblau SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Paietta EM; Montefiore Medical Center, Bronx, NY 10467, USA.
  • Rowe JM; Department of Hematology, Shaare Zedek Medicak Center, Jerusalem 910310, Israel.
  • Pui CH; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Gastier-Foster J; The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
  • Gu Z; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Reshmi S; The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
  • Loh ML; Department of Pediatrics and the Helen Diller Family Cancer Center, University of California, San Francisco, CA 94115, USA.
  • Racevskis J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Tallman MS; Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
  • Wiernik PH; Cancer Research Foundation of New York, Bronx, NY 10514, USA.
  • Litzow MR; Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
  • Willman CL; University of New Mexico Cancer Research and Treatment Center, Albuquerque, NM 87106, USA.
  • McPherson JD; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, Sacramento, CA 95817, USA.
  • Downing JR; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Zhang J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Dick JE; Princess Margaret Cancer Centre, University Health Network and Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 1L7, Canada.
  • Hunger SP; Department of Pediatrics and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: charles.mullighan@stjude.org.
Cancer Cell ; 29(2): 186-200, 2016 Feb 08.
Article em En | MEDLINE | ID: mdl-26859458
ABSTRACT
Chromosomal rearrangements are a hallmark of acute lymphoblastic leukemia (ALL) and are important ALL initiating events. We describe four different rearrangements of the erythropoietin receptor gene EPOR in Philadelphia chromosome-like (Ph-like) ALL. All of these rearrangements result in truncation of the cytoplasmic tail of EPOR at residues similar to those mutated in primary familial congenital polycythemia, with preservation of the proximal tyrosine essential for receptor activation and loss of distal regulatory residues. This resulted in deregulated EPOR expression, hypersensitivity to erythropoietin stimulation, and heightened JAK-STAT activation. Expression of truncated EPOR in mouse B cell progenitors induced ALL in vivo. Human leukemic cells with EPOR rearrangements were sensitive to JAK-STAT inhibition, suggesting a therapeutic option in high-risk ALL.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores da Eritropoetina / Ordem dos Genes / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Humans Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores da Eritropoetina / Ordem dos Genes / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Humans Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos